Compare Exelixis vs Selectx Pharmaceuticals
Customers evaluate the quality of Exelixis's products using the following success metrics.
Overview
Exelixis is 30 yrs old and is based in United States.
Exelixis (NASDAQ: EXEL) is a development-stage biotechnology company dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer.
Selectx Pharmaceuticals is 22 yrs old and is based in United States.
SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its Genetic Chemistry platform.
Demo Video
Leadership
Stelios B. Papadopoulos (Founder)
Michael G Chaparian (Chief Executive Officer)
Funding
Investors
Domain Associates, Pappas Ventures
TVM Capital, Inventages Venture Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Exelixis has not claimed their profile.
Work for Exelixis? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Exelixis?
Claim your profile now.
Information not available because Selectx Pharmaceuticals has not claimed their profile.
Work for Selectx Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Selectx Pharmaceuticals?
Claim your profile now.